CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹7.89 Cr | ₹2.13 Cr | ₹13 Cr | ₹17 Cr |
What is the latest Total Non-Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹7.89 Cr |
| Mar2023 | ₹2.13 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹17 Cr |
How is Total Non-Current Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 67.81 | |
| Mar2024 | ₹7.89 Cr | 270.42 | |
| Mar2023 | ₹2.13 Cr | -83.03 | |
| Mar2022 | ₹13 Cr | -27.83 | |
| Mar2021 | ₹17 Cr | - | |
Compare Total Non-Current Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹19,358.7 Cr | 1.6% | 28.2% | 21.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 1.6% |
28.2% |
21.6% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses